Skip to content
10-Q

Quarterly Report

Bellerophon Therapeutics, Inc.

0001558370-23-014867

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 11, 2023 12.23M sh
Shares Diluted Q2 2023 · Jun 30, 2023 12.23M sh
Shares Diluted Q2 2023 · Jun 30, 2023 11.3M sh
Shares Diluted Q2 2023 · Jun 30, 2022 9.55M sh
Shares Diluted Q2 2023 · Jun 30, 2022 9.55M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$1.66M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$8.41M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $10.58M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $6.92M
Stockholders Equity Q2 2023 · Jun 30, 2023 $5.62M
Stockholders Equity Q2 2023 · Mar 31, 2023 $10.6M
Stockholders Equity Q2 2023 · Dec 31, 2022 $2.53M
Stockholders Equity Q2 2023 · Jun 30, 2022 $12.28M
Stockholders Equity Q2 2023 · Mar 31, 2022 $16.17M
Stockholders Equity Q2 2023 · Dec 31, 2021 $21.62M
Current Liabilities Q2 2023 · Jun 30, 2023 $5.62M
Current Liabilities Q2 2023 · Dec 31, 2022 $5.4M
Total Liabilities Q2 2023 · Jun 30, 2023 $5.62M
Total Liabilities Q2 2023 · Dec 31, 2022 $5.4M
Current Assets Q2 2023 · Jun 30, 2023 $11.25M
Current Assets Q2 2023 · Dec 31, 2022 $7.56M
Total Assets Q2 2023 · Jun 30, 2023 $11.25M
Total Assets Q2 2023 · Dec 31, 2022 $7.94M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.42
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.20
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.43
Eps Diluted Q2 2023 · Jun 30, 2022 −$1.02
Eps Basic Q2 2023 · Jun 30, 2023 −$0.42
Eps Basic Q2 2023 · Jun 30, 2023 −$0.20
Eps Basic Q2 2023 · Jun 30, 2022 −$0.43
Eps Basic Q2 2023 · Jun 30, 2022 −$1.02
Sga Expense Q2 2023 · Jun 30, 2023 $2.36M
Sga Expense Q2 2023 · Jun 30, 2023 $3.97M
Sga Expense Q2 2023 · Jun 30, 2022 $2.05M
Sga Expense Q2 2023 · Jun 30, 2022 $3.29M
Net Income Q2 2023 · Jun 30, 2023 −$5.14M
Net Income Q2 2023 · Jun 30, 2023 −$2.32M
Net Income Q2 2023 · Jun 30, 2022 −$4.11M
Net Income Q2 2023 · Jun 30, 2022 −$9.75M
Operating Income Q2 2023 · Jun 30, 2023 −$5.26M
Operating Income Q2 2023 · Jun 30, 2023 −$3.78M
Operating Income Q2 2023 · Jun 30, 2022 −$6.54M
Operating Income Q2 2023 · Jun 30, 2022 −$12.18M
Revenue Q2 2023 · Jun 30, 2023 $5.64M